Main menu

NEW YORK (GenomeWeb News) – The National Institutes of Health will fund two-year grants to researchers aiming to identify novel targets within the mammalian target of rapamycin (mTOR) signaling network, which potentially could be used to promote healthy aging and extend health into old age.